🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Emeline Aviki, MD, MBA highlighting #financialtoxicity of drug packaging for women with #endometrialcancer . Devil is in the details with cost 💰 Way to go! Advocating for patients! #SGOMtg

Karen Lu J. Alejandro Rauh-Hain, MD, MPH SGO Thrilled to receive the FWC Move4Her grant! Excited to continue to work to #endcancer FdtnForWomensCancer #SGO2022 #SGOmtg

Sad to miss SGO #SGOMtg annual meeting but lucky to have the Best mentors MD Anderson Cancer Center #oncsurgery

#Editorial "Extra cycles of neoadjuvant chemotherapy before interval #surgery for #OvarianCancer: the more the merrier or too much of a good thing?" bit.ly/3QMft4F Alex Melamed Roni Nitecki Wilke ESGO IGCS Pedro T Ramirez IJGC Fellows #GynCancer #GynOnc #gyncsm

Very proud of my good friend Dr.Monica Avila doing humanitarian work and making a difference in Guatemala Moffitt Cancer Center moffitt.org/for-healthcare…

Thanks @GynOncJnls Diane Yamada for inviting us to highlight the importance of addressing #financialtoxicity in gyn cancer care. Proud of this team Emeline Aviki, MD, MBA Ross Harrison, MD MPH Roni Nitecki Wilke Kate Esselen, MD MBA Larissa Meyer authors.elsevier.com/a/1gYvdKfi8wfV1

.Shannon Westin, MD, MPH, FASCO MD Anderson Cancer Center presenting neoadjuvant Olaparib study in #BRCA mutated #ovariancancer SGO #SGOMtg #sgo2023 #oncsurgery #gyncsm

Exciting data from the SOLAR trial presented by ⁦Shannon Westin, MD, MPH, FASCO⁩ on the use of combination PARPi and MEKi for RAS mutated recurrent ovarian and endometrial cancer! #SGOmtg #oncsurgery ⁦MD Anderson Cancer Center⁩

Beautiful weekend in Monterey at #WAGO2023 #FelixRutledgeSociety meeting with our current and former MD Anderson Cancer Center colleagues and friends! #endcancer #oncsurgery

Congratulations to our superstar graduating MD Anderson Cancer Center Gyn Onc fellows Drs. How, Wilke, and Cun! 👏🏻🎉❤️ #endcancer #oncsurgery

I can’t think of a better place for #teambuilding and #wellness with our MD Anderson Cancer Center Gyn Onc fellows and colleagues! #17miledrive #pebblebeach #oncsurgery

Pics of Roni Nitecki Wilke on her first and last day at LBJ! Congrats to Roni Nitecki Wilke, Jeffrey How and Han T. Cun on their upcoming fellowship graduation! We are so proud of you and honored to have been part of your training Aaron Shafer Michaela Onstad, MD Karen Lu #OncSurgery

Huge congratulations to our ⁦MD Anderson Cancer Center⁩ graduating fellows ⁦Han T. Cun⁩ ⁦Jeffrey How⁩ ⁦Roni Nitecki Wilke⁩ !!! Proud of all you have accomplished, grateful for your dedication, and here to support you in your new roles!!! #oncsurgery ⁦Aaron Shafer⁩

📣 Join Roni Nitecki Wilke and Anne Knisely, MD as they explore the critical issue of #Racial & #Sociodemographic #Disparities in Novel #Therapeutics on our latest podcast episode. 🎧✨ Don't miss out—tune in now! 👉 bit.ly/4fc9wdE #HealthcareEquity #NovelTherapeutics

#LeadArticle Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare by Anne Knisely, MD 🔎 bit.ly/4hAl1xq Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists

Check out the November #IJGCclub! On the 20th, the IJGC editors & fellows will speak with Anne Knisely, MD & Roni Nitecki Wilke about their article on racial & socioeconomic disparities in the use of targeted therapies for advanced #ovariancancer. We look forward to the

Excited to share my latest publication in the IJGC Oncologic outcomes of incidental serous tubal intraepithelial carcinoma and associated high-grade serous carcinoma in high-risk patients undergoing risk-reducing surgery ijgc.bmj.com/content/early/… Karen Lu Roni Nitecki Wilke

#cancer during #pregnancy is associated with severe maternal and neonatal morbidity. Proud of the entire team for this important manuscript! authors.elsevier.com/c/1k7m2gm3zE9I J. Alejandro Rauh-Hain, MD, MPH Alex Melamed @markaclapp Abigail S. Zamorano, MD MPHS David Viveros-Carreño Núria Agustí Garcia MD Anderson Cancer Center AJOG

Our 15-year cohort study explores trends in surgical de-escalation in gynecologic oncology. These findings are transforming patient care but raise important questions about the preparation of fellows in surgical training. Alex Melamed David Viveros-Carreño J. Alejandro Rauh-Hain, MD, MPH Roni Nitecki Wilke

Excited about our JAMA Oncology study! Adding CHT to RT showed no OS benefit in intermediate-risk cervical cancer, aligning with GOG 263 (#SGO2025). Hope this helps refine guidelines & improve patient care. David Viveros-Carreño Alex Melamed Roni Nitecki Wilke René Pareja J. Alejandro Rauh-Hain, MD, MPH